疫苗接种延迟对肺炎球菌结合疫苗避免死亡数的影响:8国情景模型
该建模研究评估疫苗接种延迟对肺炎球菌结合疫苗(PCV)减少5岁以下儿童死亡效果的影响,模拟8个国家情景并考虑 herd protection。结果显示,在考虑群体保护时,延迟接种与按时接种避免的死亡数相当;印度情景下相对差异在低覆盖率时最大,绝对差异在约60%覆盖率时最大。
要点
- 考虑群体保护时,实际接种延迟对PCV避免死亡数影响很小。
- 高人群覆盖率可通过群体保护大幅抵消延迟接种的不良影响。
- 若不考虑群体保护,延迟接种导致避免死亡数明显减少。
核心结论
- 在考虑群体保护时,现实中的疫苗接种延迟对PCV避免的5岁以下儿童死亡数影响很小。
研究设计与样本
- 构建模型模拟从出生到5岁每周的肺炎球菌死亡风险和PCV直接保护效应,比较有无接种延迟时避免的死亡数。
- 应用于8个国家特异性接种情景,反映接种延迟、PCV覆盖率、群体效应、死亡风险和接种程序的差异。
- 另在印度评估不同延迟情景和覆盖率下接种延迟的影响。
主要发现
- 在所有国家情景中,考虑群体保护时,有延迟与无延迟时PCV避免的死亡数相当。
- 印度情景下,避免死亡数的最大相对差异出现在低覆盖率水平,最大绝对差异出现在约60%疫苗接种覆盖率时。
- 在中等延迟情景下,印度不同覆盖率或接种程序下接种延迟对PCV避免死亡数影响不大。
- 不考虑群体保护时,接种延迟导致避免死亡数失败明显更大。
临床怎么用
- 在PCV接种规划中,高人群覆盖率可通过群体保护大幅抵消接种延迟对避免死亡数的不利影响。
- 评估接种延迟影响时需考虑群体保护效应,否则可能高估延迟的危害。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Delay in vaccination from schedule has been frequently documented and varies by vaccine, dose, and setting. Vaccination delay may result in the failure to prevent deaths that would have been averted by on-schedule vaccination. We constructed a model to assess the impact of delay in vaccination with pneumococcal conjugate vaccine (PCV) on under-five mortality. The model accounted for the week of age-specific risk of pneumococcal mortality, direct effect of vaccination, and herd protection. For each model run, a cohort of children were exposed to the risk of mortality and protective effect of PCV for each week of age from birth to age five. The model was run with and without vaccination delay and difference in number of deaths averted was calculated. We applied the model to eight country-specific vaccination scenarios, reflecting variations in observed vaccination delay, PCV coverage, herd effect, mortality risk, and vaccination schedule. As PCV is currently being scaled up in India, we additionally evaluated the impact of vaccination delay in India under various delay scenarios and coverage levels. We found deaths averted by PCV with and without delay to be comparable in all of the country scenarios when accounting for herd protection. In India, the greatest relative difference in deaths averted was observed at low coverage levels and greatest absolute difference was observed around 60% vaccination coverage. Under moderate delay scenarios, vaccination delay had modest impact on deaths averted by PCV in India across levels of coverage or vaccination schedule. Without accounting for herd protection, vaccination delay resulted in much greater failure to avert deaths. Our model suggests that realistic vaccination delay has a minimal impact on the number of deaths averted by PCV when accounting for herd effect. High population coverage can largely over-ride the deleterious effect of vaccination delay through herd protection.
引用
- Carter ED, Tam Y, Walker N, et al. Impact of vaccination delay on deaths averted by pneumococcal conjugate vaccine: Modeled effects in 8 country scenarios. Vaccine. 2019. PMID: 31375441. doi:10.1016/j.vaccine.2019.07.063
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。